Friedman Center for Nutrition & Inflammation

Publications

Found 9 results
Author Title Type [ Year(Asc)]
Filters: Author is Battat, Robert  [Clear All Filters]
2023
Rajan A, Pan Y, Mahtani P, Niec R, Longman R, Gerber J, Lukin D, Scherl E, Battat R.  2023.  The Impact of Confounders on Symptom-Endoscopic Discordances in Crohn's Disease.. Crohns Colitis 360. 5(2):otad017.
Smith ES, Chen J, Pan Y, Mahtani P, Lukin D, Ahmed W, Longman R, Burakoff R, Scherl E, Battat R.  2023.  The Relationship Between the Endoscopic Healing Index, Fecal Calprotectin, and Magnetic Resonance Enterography in Crohn's Disease.. J Clin Gastroenterol.
Chen K, Chen J, Smith E, Mathani P, Longman R, Lukin D, Scherl E, Gerber J, Battat R.  2023.  Serum Ustekinumab Concentrations Are Associated With Improved Outcomes With the Magnetic Resonance Index of Activity for Crohn's Disease.. Inflamm Bowel Dis. 29(9):1499-1503.
2022
Ahmed W, Galati J, Kumar A, Christos PJ, Longman R, Lukin DJ, Scherl E, Battat R.  2022.  Dual Biologic or Small Molecule Therapy for Treatment of Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.. Clin Gastroenterol Hepatol. 20(3):e361-e379.
Battat R, Galati JS, Lukin D, Chabouni F, Sockolow R, Carter J, Fajardo K, Yang S, Reich J, Jacobs V et al..  2022.  A Quality Improvement Initiative Is Associated With Reduced Time to Administer Biologics and Small Molecules and Emergency Room Visits in Inflammatory Bowel Disease.. J Clin Gastroenterol. 56(3):e176-e182.
Pan Y, Ahmed W, Mahtani P, Wong R, Longman R, Lukin DJeremy, Scherl EJ, Battat R.  2022.  Utility of Therapeutic Drug Monitoring for Tumor Necrosis Factor Antagonists and Ustekinumab in Postoperative Crohn's Disease.. Inflamm Bowel Dis.
2021
Charilaou P, Tricarico C, Battat R, Scherl EJ, Longman RS, Lukin DJ.  2021.  Impact of Inflammatory Bowel Disease Therapies on Durability of Humoral Response to SARS-CoV-2 Vaccination.. Clin Gastroenterol Hepatol.
Ma C, Sedano R, Almradi A, Casteele NVande, Parker CE, Guizzetti L, Schaeffer DF, Riddell RH, Pai RK, Battat R et al..  2021.  An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials.. Gastroenterology. 160(7):2291-2302.
Lukin DJ, Funez-dePagnier G, Lima S, Lai D, Duenas-Bianchi L, Ahmed W, Jacob V, Battat R, Scherl E, Longman RS.  2021.  No Durable Impact of COVID-19 on Intestinal Disease Activity in Subjects With IBD.. Clin Gastroenterol Hepatol. 19(11):2312-2314.e3.